Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Allorecognition].

Y Lebranchu1

  • 1CHU de Tours.

Presse Medicale (Paris, France : 1983)
|October 2, 2001
PubMed
Summary

Understanding direct and indirect recognition is key to managing transplant rejection. Targeting T cell receptor activation pathways may offer improved immunosuppression strategies for graft tolerance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Advances in transplantation: Conclusion].

Bulletin de l'Academie nationale de medecine·2022
Same author

Intravenous Immunoglobulins in the Prevention of Rejection of a Second or Third Kidney Graft.

Transplantation proceedings·2018
Same author

Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Genome-Wide Association Study of Acute Renal Graft Rejection.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Mycophenolate mofetil in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: a prospective pharmacokinetics and clinical study.

Clinical and experimental immunology·2013
Same author

Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.

The New England journal of medicine·2013

Area of Science:

  • Immunology
  • Transplantation immunology

Background:

  • Two primary mechanisms, direct and indirect recognition, mediate T cell responses to allografts.
  • Direct recognition involves recipient T cells recognizing intact donor antigens on donor antigen-presenting cells, primarily driving acute rejection.
  • Indirect recognition involves recipient antigen-presenting cells processing donor antigens, contributing to both acute and chronic rejection, and antibody formation.

Framework:

  • Direct recognition is characterized by naive T cell interaction with donor dendritic cells in lymphoid organs, explaining early acute rejection.
  • Indirect recognition, a less intense but crucial mechanism, is implicated in chronic rejection and involves CD4+ T cell activation.

Implementation:

  • Activated CD4+ T cells via indirect recognition promote B cell activation, leading to anti-HLA antibody production.
  • These activated cells also stimulate macrophages, monocytes, endothelial cells, and smooth muscle cells, contributing to graft damage.
  • Potential strategies for inducing tolerance include modulating interleukin-2 consumption, producing suppressive cytokines, or utilizing cell-cell contact inhibition.

Implications:

  • Understanding intracellular signaling pathways post-T cell receptor activation presents novel therapeutic targets.
  • Targeting key proteins in T cell activation could lead to more effective immunosuppression than current calcineurin inhibitors.
  • This knowledge is crucial for developing advanced strategies to prevent transplant rejection and promote long-term graft survival.

Related Experiment Videos